ARTICLE | Company News
Drais, Unibioscreen deal
September 22, 2008 7:00 AM UTC
Drais received exclusive, worldwide rights from Unibioscreen to develop and commercialize UNBS 5162 for all indications. Unibioscreen is eligibe for up to $31 million in an upfront payment and milesto...